nav-left cat-right
cat-right

Canagliflozin Amputee Attorney

Invokana and Invokamet are classified as SGLT2 inhibitors, a class of drugs prescribed to treat patients with Type 2 diabetes.When the third phase of the research showed benefits in lowering glucose in patients with diabetes, the FDA approved Invokana in 2013.Agreed to Canagliflozin amputee attorney conduct additional post-market studies of its drug for the following:Reported in The Journal of Clinical Endocrinology & Metabolism – Invokana and Ketoacidosis.These factors include a history of prior amputation, peripheral vascular disease, neuropathy, and diabetic foot ulcers.Lawsuits are also being filed in the U.S. and other countries alleging that Invokana can cause serious kidney problems, including kidney failure.If you or a loved one has developed diabetic ketoacidosis, kidney damage, suffered a heart attack, fractured a bone, or have had a lower limb amputated as a result of any of these or similar diabetes medications (known as SGLT2 inhibitors) you may be entitled to compensation.

Invokana isn’t the first drug found to have a dangerous side effect after it received FDA approval.Call today to learn more or to schedule a free consultation on your case.Ketoacidosis occurs when the body cannot break down sugars in the blood due to a lack of insulin.

Norton said that in her role as an emergency room physician at Scripps Mercy Hospital she personally saw a very sick patient with diabetic ketoacidosis, which was thought to be a side effect of taking Invokamet.It may be that the drug inhibits the flushing of excess ketones, resulting in an unhealthy pH balance in the blood.Among those cases, 86% involved patients who had been taking Invokana.Drug Safety Communication (PDF – 81KB)We are currently working to help Invokana patients who have experienced diabetic ketoacidosis or kidney failure while taking Invokana or shortly after stopping Invokana.The last thing you want is a medication that might cause more harm than good.Calls and evaluations are free.Of the amputees who were taking canafliglozin, most were men, and had an average age of about 60.

Hypersensitivity Response— Autoimmune response caused by over-reaction of the immune system, typically with hours or days of starting the medication.The litigation will be coordinated in the U.S. District Court for New Jersey under Judge Brian R. Martinotti — the same venue lawyers requested in a motion filed in September.This consultation is FREE.In some cases, only part of the toe is removed.

In December 2015, the FDA also issued a caution that the diabetes drug could be linked to blood infections.These clinical trial results are astounding and show that Janssen did not conduct adequate testing prior to marketing Invokana or properly warn patients about the severe risks of taking the drug.

Comments are closed.